Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 3,4 Dihydroquinazolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110776470B details an iridium-catalyzed asymmetric hydrogenation method for chiral 3,4-dihydroquinazolinones with up to 98% ee, offering a scalable route for API intermediates.